BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 8626409)

  • 21. Stability of drug-induced tubulin rings by fluorescence correlation spectroscopy.
    Boukari H; Nossal R; Sackett DL
    Biochemistry; 2003 Feb; 42(5):1292-300. PubMed ID: 12564932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dolastatin 15 binds in the vinca domain of tubulin as demonstrated by Hummel-Dreyer chromatography.
    Cruz-Monserrate Z; Mullaney JT; Harran PG; Pettit GR; Hamel E
    Eur J Biochem; 2003 Sep; 270(18):3822-8. PubMed ID: 12950266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of tubulin-microtubule polymerization by drugs of the Vinca alkaloid class.
    Owellen RJ; Hartke CA; Dickerson RM; Hains FO
    Cancer Res; 1976 Apr; 36(4):1499-502. PubMed ID: 1260766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of arenastatin A with porcine brain tubulin.
    Morita K; Koiso Y; Hashimoto Y; Kobayashi M; Wang W; Ohyabu N; Iwasaki S
    Biol Pharm Bull; 1997 Feb; 20(2):171-4. PubMed ID: 9057981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Localization of the antimitotic peptide and depsipeptide binding site on beta-tubulin.
    Mitra A; Sept D
    Biochemistry; 2004 Nov; 43(44):13955-62. PubMed ID: 15518544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physiochemical aspects of tubulin-interacting antimitotic drugs.
    Correia JJ; Lobert S
    Curr Pharm Des; 2001 Sep; 7(13):1213-28. PubMed ID: 11472263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Halohydrin analogues of cryptophycin 1: synthesis and biological activity.
    Georg GI; Ali SM; Stella VJ; Waugh WN; Himes RH
    Bioorg Med Chem Lett; 1998 Aug; 8(15):1959-62. PubMed ID: 9873466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimitotic and tubulin-interacting properties of vinflunine, a novel fluorinated Vinca alkaloid.
    Kruczynski A; Barret JM; Etiévant C; Colpaert F; Fahy J; Hill BT
    Biochem Pharmacol; 1998 Mar; 55(5):635-48. PubMed ID: 9515574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of microtubule dynamics by drugs: a paradigm for the actions of cellular regulators.
    Wilson L; Panda D; Jordan MA
    Cell Struct Funct; 1999 Oct; 24(5):329-35. PubMed ID: 15216890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indirubin, a bis-indole alkaloid binds to tubulin and exhibits antimitotic activity against HeLa cells in synergism with vinblastine.
    Mohan L; Raghav D; Ashraf SM; Sebastian J; Rathinasamy K
    Biomed Pharmacother; 2018 Sep; 105():506-517. PubMed ID: 29883946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymerization of the tubulin-colchicine complex and guanosine 5'-triphosphate hydrolysis.
    Saltarelli D; Pantaloni D
    Biochemistry; 1982 Jun; 21(12):2996-3006. PubMed ID: 7104309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of antimitotic agents on tubulin-nucleotide interactions.
    Correia JJ
    Pharmacol Ther; 1991 Nov; 52(2):127-47. PubMed ID: 1818332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of marine toxin dolastatin 10 with porcine brain tubulin: competitive inhibition of rhizoxin and phomopsin A binding.
    Li Y; Kobayashi H; Hashimoto Y; Shirai R; Hirata A; Hayashi K; Hamada Y; Shioiri T; Iwasaki S
    Chem Biol Interact; 1994 Dec; 93(3):175-83. PubMed ID: 7923438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Photoaffinity labeling of tubulin subunits with a photoactive analogue of vinblastine.
    Safa AR; Hamel E; Felsted RL
    Biochemistry; 1987 Jan; 26(1):97-102. PubMed ID: 3828312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of vinca alkaloids with tubulin: a comparison of vinblastine, vincristine, and vinorelbine.
    Lobert S; Vulevic B; Correia JJ
    Biochemistry; 1996 May; 35(21):6806-14. PubMed ID: 8639632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of tubulin polymerization by vitilevuamide, a bicyclic marine peptide, at a site distinct from colchicine, the vinca alkaloids, and dolastatin 10.
    Edler MC; Fernandez AM; Lassota P; Ireland CM; Barrows LR
    Biochem Pharmacol; 2002 Feb; 63(4):707-15. PubMed ID: 11992639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stabilization of microtubule dynamics by estramustine by binding to a novel site in tubulin: a possible mechanistic basis for its antitumor action.
    Panda D; Miller HP; Islam K; Wilson L
    Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10560-4. PubMed ID: 9380674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of active isomers, segments, and analogs of dolastatin 10 on ligand interactions with tubulin. Correlation with cytotoxicity.
    Bai R; Roach MC; Jayaram SK; Barkoczy J; Pettit GR; Ludueña RF; Hamel E
    Biochem Pharmacol; 1993 Apr; 45(7):1503-15. PubMed ID: 8471072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perturbation of microtubule polymerization by quercetin through tubulin binding: a novel mechanism of its antiproliferative activity.
    Gupta K; Panda D
    Biochemistry; 2002 Oct; 41(43):13029-38. PubMed ID: 12390030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of antimitotic drugs on tubulin GTPase activity and self-assembly.
    David-Pfeuty T; Simon C; Pantaloni D
    J Biol Chem; 1979 Nov; 254(22):11696-702. PubMed ID: 227875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.